PHP92 - The Growth of Cost-Effectiveness Analyses in Asia

Autor: Neumann, PJ, D'Cruz, BN, Emerson, JG, Panzer, AD, Anderson, JE, Pope, E, Kim, DD, Cohen, JT

Publikováno v: In Value in Health September 2018 21 Supplement 2:S56-S56

Specialty drug coverage varies between health plans' medical and pharmacy benefit policies.

Autor: Levine AA; The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Panzer AD; The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Kauf TL; HEOR, Alkermes, Inc., Waltham, MA., O'Sullivan AK; Ontada, Newburyport, MA., Strand L; HEOR, Alkermes, Inc., Waltham, MA., Chambers JD; The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Jun; Vol. 29 (6), pp. 607-613.

Examining US commercial health plans' use of The Institute for Clinical and Economic Review's reports in specialty drug coverage decisions.

Autor: Chambers JD; The Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Enright DE; The Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Panzer AD; The Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Cohen JT; The Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Ollendorf DA; The Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA., Neumann PJ; The Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Mar; Vol. 29 (3), pp. 257-264.

Patients' access to 2018 FDA-approved drugs 1 year post approval.

Autor: Panzer AD; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St #63, Boston, MA 02111. Email: apanzer@tuftsmedicalcenter.org., Margaretos NM, Bridger N, Osani MC, Lai RC, Chambers JD

Publikováno v: The American journal of managed care [Am J Manag Care] 2022 Apr 01; Vol. 28 (4), pp. e153-e156. Date of Electronic Publication: 2022 Apr 01.

Variation in health plan coverage of ESAs for anemia due to chronic kidney disease.

Autor: Margaretos NM; Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Center for the Evaluation of Value and Risk in Health, Boston, MA., Panzer AD; Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Center for the Evaluation of Value and Risk in Health, Boston, MA., Lai RC; Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Center for the Evaluation of Value and Risk in Health, Boston, MA., Sanon M; Otsuka Pharmaceutical Development & Commercialization, Princeton, NJ., Michalopoulos E; Otsuka Pharmaceutical Development & Commercialization, Princeton, NJ., Redmond AM; Otsuka Pharmaceutical Development & Commercialization, Princeton, NJ., Moghadam R; Otsuka Pharmaceutical Development & Commercialization, Princeton, NJ., Chambers JD; Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Center for the Evaluation of Value and Risk in Health, Boston, MA.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2021 Sep; Vol. 27 (9), pp. 1221-1229.